Case Discussion: DMD

The France Foundation

C. Proud, A. Veerapandiyan, C. Mcdonald

Year in Review: Recent Advances in NMDs Therapies

Bassam A. Bassam

DMD Management in the Era of Gene Therapy

The France Foundation

A. Veerapandiyan, C. Zaidman

Impact of Combination Therapies and Exercise Programs for Neuromuscu…

The France Foundation

A. Veerapandiyan, J. Brandsema, L. Servais

Emerging Therapies for Neuromuscular Diseases in 2021: ALS, Dystroph…

Houston Methodist

E. Greene

Approach to a Child with Delayed Walking

UCSF School of Medicine

Y. Mitsuya

Newborn Screening Programs: Development, Implementation, and the Roa…

Muscular Dystrophy Association

M. Caggana

Genetic Testing and Counseling for Neuromuscular Diseases

Muscular Dystrophy Association

L. Gutmann, S. Feely

The Technology Will See You Now: Digital Endpoints and AI Applicatio…

Henry J. Kaminski

Cell-Based Therapies for Neuromuscular Diseases

Houston Methodist

B. Liao

Principles of AAV Gene Therapy for Inherited Neurological Disorders:…

American Neurological Association

S. G. Kaler, B. Traynor

Newborn Screening for Duchenne Muscular Dystrophy

United Scientific Group

R. Rodney Howell

Pediatric Indications for Botulinum Toxin

UCSF School of Medicine

K. Sigford

Improving the Management of Patients With DMD: Emerging Evidence and…

The France Foundation

C. Proud, E. Finanger

Clinical Updates in DMD

The France Foundation

J. Brandsema, A. Veerapandiyan, L. Servais

Introduction to Dystrophin

The France Foundation

C. Mcdonald

Therapies for DMD

The France Foundation

C. Mcdonald

Implementation and Follow-up for Infants Identified Through Newborn …

Muscular Dystrophy Association

D. Kronn

Pediatric Neuromuscular Disorders

ZINCARE

J. Wilmshurst

Heterogeneity in Muscular Dystrophies

The France Foundation

L. Servais, J. Brandsema